EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma lipidomics, choline metabolites, and metabolic-associated steatotic liver disease (MASLD): A Coronary Artery Risk Development in Young Adults (CARDIA) study

Jessica K Sprinkles iD, Qiyao Qin iD, Charles Steward iD, Annie Green Howard, Anju Lulla, Autumn G Hullings, J Jeffrey Carr, Saame Raza Shaikh, Christy L Avery, Kari E North, Penny Gordon-Larsen iD, Katie A Meyer

PLOS One · 13.03.2026 · 21 (3) · e0341462

DOI: 10.1371/journal.pone.0341462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 13.03.2026. Verfasst von Jessica K Sprinkles und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United St…. Hauptthemen laut MEDLINE: Choline, Lipidomics, Coronary Artery Disease, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, National Heart, Lung, and Blood Institute, Balchem.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic-associated steatotic liver disease (MASLD) is marked by accumulation of hepatic triacylglycerols (TAG), but many other lipids have been implicated. Choline metabolism has been shown to be related to MASLD, specifically through phosphatidylcholines (PC) role in hepatic TAG removal through very low density lipoproteins (VLDL). There are a lack of population-based studies with integrated data on lipidomics, choline metabolites, and MASLD. We tested associations between the plasma lipidome, choline metabolites, and MASLD using data from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. The analytic sample included 1,039 participants with data on choline metabolite, lipidomic, and liver attenuation data [mean (SD) age: 45 (4); 57% female; 57% White race]. MASLD (n = 234) was defined as mean CT-derived liver attenuation < 51HU. Plasma lipidomics and choline metabolites were quantified from stored fasting plasma using liquid-chromatography and infusion-mass spectrometry. In logistic regression adjusted for sociodemographics, lifestyle, and clinical variables, total TAGs, diacylglycerols (DAG), and dihydroceramides (DCER) were positively, and lactosylceramides (LCER) were inversely, associated with MASLD. Species-level results revealed diverging MASLD associations for PCs, based on FA composition. In choline metabolite models, betaine was inversely associated with MASLD. A lipidomic risk score (LRS) derived from penalized regression of MASLD on lipid species was associated positively with choline, and inversely with betaine. We contribute population-based results to a growing literature relating lipidomics and MASLD. In our data, FA composition is biologically relevant to MASLD, particularly for PCs and TAGs. Our results link choline metabolites to both the plasma lipidome and to incident MASLD, furthering efforts in biomarker development and supporting mechanistic evidence using population-level data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholineLipidomicsCoronary Artery DiseaseFatty LiverHumansFemaleMaleAdultTriglyceridesMiddle AgedYoung AdultRisk FactorsPhosphatidylcholines

Substanzen

CholineTriglyceridesPhosphatidylcholines

Autor:innen und Institutionen

  • Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, North Carolina, United States of America.
  • Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

ORCID-Profile: Jessica K Sprinkles, Qiyao Qin, Charles Steward, Penny Gordon-Larsen

Förderung

  • NIEHS NIH HHS
  • National Heart, Lung, and Blood Institute
  • Balchem
  • State of North Carolina

Zitieren

APA

Sprinkles, J. K., Qin, Q., Steward, C., Howard, A. G., Lulla, A., Hullings, A. G., Carr, J. J., Shaikh, S. R., Avery, C. L., North, K. E., Gordon-Larsen, P., & Meyer, K. A. (2026). Plasma lipidomics, choline metabolites, and metabolic-associated steatotic liver disease (MASLD): A Coronary Artery Risk Development in Young Adults (CARDIA) study. PLOS One, 21(3), e0341462. https://doi.org/10.1371/journal.pone.0341462

Vancouver

Sprinkles JK, Qin Q, Steward C, Howard AG, Lulla A, Hullings AG, et al. Plasma lipidomics, choline metabolites, and metabolic-associated steatotic liver disease (MASLD): A Coronary Artery Risk Development in Young Adults (CARDIA) study. PLOS One. 2026;21(3):e0341462. doi:10.1371/journal.pone.0341462

BibTeX
@article{Sprinkles2026,
  author = {Sprinkles, Jessica K and Qin, Qiyao and Steward, Charles and Howard, Annie Green and Lulla, Anju and Hullings, Autumn G and Carr, J Jeffrey and Shaikh, Saame Raza and Avery, Christy L and North, Kari E and Gordon-Larsen, Penny and Meyer, Katie A},
  title = {Plasma lipidomics, choline metabolites, and metabolic-associated steatotic liver disease (MASLD): A Coronary Artery Risk Development in Young Adults (CARDIA) study},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0341462},
  doi = {10.1371/journal.pone.0341462}
}
Kostenlos starten →